Replies to post #37068 on Applied DNA Sciences Inc (APDN)

[Bikle]

From the Vandalia PR:

'A new capacity for APDN will be the ability to manufacture longer DNA sequences valuable in gene therapy, DNA vaccines and diagnostics. These types of DNA are distinct from APDN’s security markers and represent a new entry into medical markets, where management believes there are ample opportunities for APDN’s broader platform.'


Apart from the tagging APDN seeks to enter yet another market: gene therapy, DNA vaccines and diagnostics. That's not small business but a whole world. Think of he new immunotherapeutic cancer treatments that rely on genetically engineered polynucleases.